Latest Stock Buy or Sell?

Positioning, when bear/bull calls are split 50/50. Expect more market volatility, as seen in the last few months. 87% invested in two dozen tech vendors and end users, coupled with a 61% short equity indices overlay (hedge) on the invested stock portfolio. The hedge protects the portfolio if the stock market were to deteriorate. He has laddered NASDAQ put options. That hedge will incrementally grow as the delta on those put options starts to grow.

Upside missed with hedges in place? It's like an insurance policy, which has a premium attached to it. The beta in the stock market is greater than the beta on the hedge. As the market continues to melt up, he makes money, though perhaps not as much as the NASDAQ. Their benchmark, chosen by the OSC, is 50/50 NASDAQ/Russell, so it gets both sides of the cyclical/growth play. He doesn't make as much, but he's certainly protected on the downside. If the downside is more than 5-10%, the hedge makes money for his fund.

Price target of $385.25. 99% of revenues are from advertising. CEO has referred to the metaverse, a virtual environment, but it will take a while to get there. Attractively priced, growing at 25%. Future eyes will be on its user growth. If you can pick it up between $275-325, you'll do very, very well.

Price target of $313.25. Continues to show the uniqueness of its enterprise IT positioning. He expects earnings to rise in near future, but at a slower rate than growth expectations implied by current valuations. Hold on, and definitely buy on dips.

Price target is $166.85. Platform to get healthcare from a variety of professionals. Has grown revenue significantly, leader in the category of med-tech. Volatile. Yet to be profitable. A number of acquisitions. Still likes it.

Leader in collaboration. Lots of competition. Aims to provide clarity at every level of an organization. Phenomenal company. Great leadership. He sold at his price target. It's rich.